This site is intended for healthcare professionals only
LoginRegister
Cipla, Hetero win bid to supply widely prescribed diabetes drug in ChinaWockhardt sells USFDA-approved migraine tablet to Senores Pharma
Morepen Labs Naresh Sharma resigns as Vice President - Operations (API)Morepen Labs Naresh Sharma resigns as Vice President - Operations (API)
Roche Breast Cancer Drug Giredestrant Fails Late-Stage Trial GoalRoche launches Elecsys PRO-C3 test for liver fibrosis
Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus DealCDSCO Panel approves Eli Lilly proposal to Increase patients number from India 37 to 57 for ...
Sanofis Diabetes Drug Lantus SoloStar Insulin Batch Stolen, CDSCO Issues AlertSanofi Healthcare India Gets CDSCO Panel Nod To study SAR441566
Substandard Deworming Medicines DetectedSubstandard Drugs to Face Immediate License Suspension Under DTAB's New Recommendation
Star Health names Rajeev Kher as Chairperson of BoardStar Health names Rajeev Kher as Chairperson of Board
Five Pharma Firms Under Regulatory Scanner Over Rs 8 Lakh Unbilled MedicinesShilpa Biologics Dharwad site gets European GMP certification
Biocon Secures USFDA Nod for Generic Liraglutide Prefilled Pens for DiabetesBiocon Biologics secures multiple market access agreements in US for Yesintek
WHO plans to back use of weight-loss drugs for adults globallyWHO to back use of weight-loss drugs as obesity treatment in adults
Azithromycin, Ofloxacin Combos Among 3 Drug Batches Flagged as Purportedly Spurious by CDSCOBatch of Tofajak Tablets earlier classified as NSQ now flagged as Spurious
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusCDSCO Panel Approves AstraZeneca's Protocol Amendment for Anti-cancer Drug AZD0901 study
X